Glycemic control through pharmaceutical care: a meta-analysis of randomized controlled trials

Zaheer Ud Din Babar, Rozina Kousar, Syed Shahzad Hasan, Shane Scahill, Louise Elizabeth Curley

Research output: Contribution to journalReview article

Abstract

Objectives: To evaluate the effect of pharmaceutical care (PC) on glycemic control in patients with type 2 diabetes mellitus. Methods: A systematic search of literature was conducted to identify randomized controlled trials (RCTs) in patients with type 2 diabetes mellitus. RCTs published in English between January 2011 and November 2015 were identified using nine electronic databases: MEDLINE, International Pharmaceutical Abstracts (IPA), EMBASE, Scopus, Science Direct, Cochrane Library, Web of Science, Springer Link, and Google Scholar. Studies were included if they outlined a pharmaceutical care intervention conducted by pharmacists alone or in collaboration with other health care professional(s). The studies were identified and data was extracted independently by two reviewers. The meta-analysis was conducted by using RevMan version 5.3. A random-effects model was used to calculate the standard mean difference (SMD) with a 95% confidence interval in glycosylated haemoglobin (HbA1C) levels. Key findings: Thirteen RCTs outlining PC interventions in type 2 diabetes mellitus patients (n = 1828) were included. The interventions included care plan development, medication reviews, patient education and counselling of patients with follow-up. All RCTs reported statistically significant reductions in HbA1c in the intervention group (SMD = −0.97; 95% CI −1.21 to −0.73; P = 0.00001) as compared to the control group. Significant heterogeneity in SMD (χ2 = 68.96) was observed. Conclusions: The findings suggest that PC interventions are effective (at least in short-term follow-up in hospital setting) in reducing HbA1c levels in patients with type 2 diabetes mellitus. Pharmacists, working alone or in collaboration with other health professionals have significant impact on improving the health status of patients with type 2 diabetes mellitus.

LanguageEnglish
Pages35-44
Number of pages10
JournalJournal of Pharmaceutical Health Services Research
Volume10
Issue number1
Early online date18 Jan 2019
DOIs
Publication statusPublished - 1 Mar 2019

Fingerprint

Pharmaceutical Services
Type 2 Diabetes Mellitus
Meta-Analysis
Randomized Controlled Trials
Patient Education
Pharmacists
Library Science
Glycosylated Hemoglobin A
MEDLINE
Health Status
Counseling
Pharmaceuticals
Randomized controlled trial
Meta-analysis
Databases
Confidence Intervals
Delivery of Health Care
Control Groups
Health
Diabetes mellitus

Cite this

@article{b285c6062fe148118aeb5cf26e3a2a5f,
title = "Glycemic control through pharmaceutical care: a meta-analysis of randomized controlled trials",
abstract = "Objectives: To evaluate the effect of pharmaceutical care (PC) on glycemic control in patients with type 2 diabetes mellitus. Methods: A systematic search of literature was conducted to identify randomized controlled trials (RCTs) in patients with type 2 diabetes mellitus. RCTs published in English between January 2011 and November 2015 were identified using nine electronic databases: MEDLINE, International Pharmaceutical Abstracts (IPA), EMBASE, Scopus, Science Direct, Cochrane Library, Web of Science, Springer Link, and Google Scholar. Studies were included if they outlined a pharmaceutical care intervention conducted by pharmacists alone or in collaboration with other health care professional(s). The studies were identified and data was extracted independently by two reviewers. The meta-analysis was conducted by using RevMan version 5.3. A random-effects model was used to calculate the standard mean difference (SMD) with a 95{\%} confidence interval in glycosylated haemoglobin (HbA1C) levels. Key findings: Thirteen RCTs outlining PC interventions in type 2 diabetes mellitus patients (n = 1828) were included. The interventions included care plan development, medication reviews, patient education and counselling of patients with follow-up. All RCTs reported statistically significant reductions in HbA1c in the intervention group (SMD = −0.97; 95{\%} CI −1.21 to −0.73; P = 0.00001) as compared to the control group. Significant heterogeneity in SMD (χ2 = 68.96) was observed. Conclusions: The findings suggest that PC interventions are effective (at least in short-term follow-up in hospital setting) in reducing HbA1c levels in patients with type 2 diabetes mellitus. Pharmacists, working alone or in collaboration with other health professionals have significant impact on improving the health status of patients with type 2 diabetes mellitus.",
keywords = "glycemic control, meta-analysis, pharmaceutical care, randomized controlled trial",
author = "Babar, {Zaheer Ud Din} and Rozina Kousar and Hasan, {Syed Shahzad} and Shane Scahill and Curley, {Louise Elizabeth}",
year = "2019",
month = "3",
day = "1",
doi = "10.1111/jphs.12281",
language = "English",
volume = "10",
pages = "35--44",
journal = "Journal of Pharmaceutical Health Services Research",
issn = "1759-8885",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

Glycemic control through pharmaceutical care : a meta-analysis of randomized controlled trials. / Babar, Zaheer Ud Din; Kousar, Rozina; Hasan, Syed Shahzad; Scahill, Shane; Curley, Louise Elizabeth.

In: Journal of Pharmaceutical Health Services Research, Vol. 10, No. 1, 01.03.2019, p. 35-44.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Glycemic control through pharmaceutical care

T2 - Journal of Pharmaceutical Health Services Research

AU - Babar, Zaheer Ud Din

AU - Kousar, Rozina

AU - Hasan, Syed Shahzad

AU - Scahill, Shane

AU - Curley, Louise Elizabeth

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Objectives: To evaluate the effect of pharmaceutical care (PC) on glycemic control in patients with type 2 diabetes mellitus. Methods: A systematic search of literature was conducted to identify randomized controlled trials (RCTs) in patients with type 2 diabetes mellitus. RCTs published in English between January 2011 and November 2015 were identified using nine electronic databases: MEDLINE, International Pharmaceutical Abstracts (IPA), EMBASE, Scopus, Science Direct, Cochrane Library, Web of Science, Springer Link, and Google Scholar. Studies were included if they outlined a pharmaceutical care intervention conducted by pharmacists alone or in collaboration with other health care professional(s). The studies were identified and data was extracted independently by two reviewers. The meta-analysis was conducted by using RevMan version 5.3. A random-effects model was used to calculate the standard mean difference (SMD) with a 95% confidence interval in glycosylated haemoglobin (HbA1C) levels. Key findings: Thirteen RCTs outlining PC interventions in type 2 diabetes mellitus patients (n = 1828) were included. The interventions included care plan development, medication reviews, patient education and counselling of patients with follow-up. All RCTs reported statistically significant reductions in HbA1c in the intervention group (SMD = −0.97; 95% CI −1.21 to −0.73; P = 0.00001) as compared to the control group. Significant heterogeneity in SMD (χ2 = 68.96) was observed. Conclusions: The findings suggest that PC interventions are effective (at least in short-term follow-up in hospital setting) in reducing HbA1c levels in patients with type 2 diabetes mellitus. Pharmacists, working alone or in collaboration with other health professionals have significant impact on improving the health status of patients with type 2 diabetes mellitus.

AB - Objectives: To evaluate the effect of pharmaceutical care (PC) on glycemic control in patients with type 2 diabetes mellitus. Methods: A systematic search of literature was conducted to identify randomized controlled trials (RCTs) in patients with type 2 diabetes mellitus. RCTs published in English between January 2011 and November 2015 were identified using nine electronic databases: MEDLINE, International Pharmaceutical Abstracts (IPA), EMBASE, Scopus, Science Direct, Cochrane Library, Web of Science, Springer Link, and Google Scholar. Studies were included if they outlined a pharmaceutical care intervention conducted by pharmacists alone or in collaboration with other health care professional(s). The studies were identified and data was extracted independently by two reviewers. The meta-analysis was conducted by using RevMan version 5.3. A random-effects model was used to calculate the standard mean difference (SMD) with a 95% confidence interval in glycosylated haemoglobin (HbA1C) levels. Key findings: Thirteen RCTs outlining PC interventions in type 2 diabetes mellitus patients (n = 1828) were included. The interventions included care plan development, medication reviews, patient education and counselling of patients with follow-up. All RCTs reported statistically significant reductions in HbA1c in the intervention group (SMD = −0.97; 95% CI −1.21 to −0.73; P = 0.00001) as compared to the control group. Significant heterogeneity in SMD (χ2 = 68.96) was observed. Conclusions: The findings suggest that PC interventions are effective (at least in short-term follow-up in hospital setting) in reducing HbA1c levels in patients with type 2 diabetes mellitus. Pharmacists, working alone or in collaboration with other health professionals have significant impact on improving the health status of patients with type 2 diabetes mellitus.

KW - glycemic control

KW - meta-analysis

KW - pharmaceutical care

KW - randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=85060193369&partnerID=8YFLogxK

U2 - 10.1111/jphs.12281

DO - 10.1111/jphs.12281

M3 - Review article

VL - 10

SP - 35

EP - 44

JO - Journal of Pharmaceutical Health Services Research

JF - Journal of Pharmaceutical Health Services Research

SN - 1759-8885

IS - 1

ER -